Conolidine’s analgesic outcomes stem from its conversation with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors inside the central anxious technique, conolidine modulates alternate molecular targets. A Science Developments analyze discovered that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXC